Ravgen settles patent fight with Illumina over genetic testing
By Blake Brittain (Reuters) – Gene-sequencing giant Illumina Inc has settled a patent lawsuit brought by Maryland biotech company Ravgen Inc, which accused Illumina’s genetic …